@article{Juli__2021,<br/><span class="tab"></span> title={Targeting of the CD80/86 proinflammatory axis as a therapeutic strategy to prevent severe COVID-19},<br/><span class="tab"></span> volume={11},<br/><span class="tab"></span> ISSN={2045-2322},<br/><span class="tab"></span> url={http://dx.doi.org/10.1038/s41598-021-90797-0},<br/><span class="tab"></span> DOI={10.1038/s41598-021-90797-0},<br/><span class="tab"></span> number={1},<br/><span class="tab"></span> journal={Scientific Reports},<br/><span class="tab"></span> publisher={Springer Science and Business Media LLC},<br/><span class="tab"></span> author={Julià,<br/><span class="tab"></span> Antonio and Bonafonte-Pardàs,<br/><span class="tab"></span> Irene and Gómez,<br/><span class="tab"></span> Antonio and López-Lasanta,<br/><span class="tab"></span> María and López-Corbeto,<br/><span class="tab"></span> Mireia and Martínez-Mateu,<br/><span class="tab"></span> Sergio H. and Lladós,<br/><span class="tab"></span> Jordi and Rodríguez-Nunez,<br/><span class="tab"></span> Iván and Myers,<br/><span class="tab"></span> Richard M. and Marsal,<br/><span class="tab"></span> Sara},<br/><span class="tab"></span> year={2021},<br/><span class="tab"></span> month=jun }